April Johnson, APRN, CNP

Dementia is more common in patients with rheumatoid arthritis who receive conventional synthetic disease modifying anti-rheumatic drugs vs. biologics or targeted synthetic treatments, according to data.

Dementia is more common in patients with rheumatoid arthritis who receive conventional synthetic disease modifying anti-rheumatic drugs vs. biologics or targeted synthetic treatments, according to data.

Prenatal exposure to hydroxychloroquine in birthing parents with systemic lupus erythematosus results in no significant adverse outcomes in children from breast feeding through 17 years, according to data published in Rheumatology.

Tofacitinib is associated with a numerically higher incidence of major adverse cardiac events, versus TNF inhibitors, in patients with rheumatoid arthritis at an increased cardiac risk, according to data presented at ACR Convergence 2021.

Approximately 84% of patients with autoimmune diseases develop antibodies from the COVID-19 vaccine, compared with 98.1% of healthy health care workers, according to an interim analysis published in MedRxiv.

Patients who received rheumatology care from nurse practitioners or physician assistants rated their overall experience similarly to those who saw a rheumatologist, according to survey data published in Arthritis Care & Research.

Fatigue and Raynaud’s syndrome were rated “important” or “very important” as barriers to physical activity in at least 50% of patients with systemic sclerosis, according to survey results published in Arthritis Care & Research.

A 2-year randomized controlled trial has found that belimumab plus standard therapy is superior to standard therapy alone in patients with lupus nephritis, according to data published in the New England Journal of Medicine.